论文部分内容阅读
基因工程抗体 (GEA)发展十分迅速 ,利用其特异性的靶向作用 ,在肿瘤诊断、治疗及预后等方面已初步显示良好效果和广阔应用前景。随着研究的不断深入 ,基因工程抗体必将发挥更重要的作用。现综述基因工程抗体在肿瘤应用中的最新进展。
Genetically engineered antibodies (GEA) develop rapidly and utilize their specific targeting effects to initially demonstrate good results and broad application prospects in the diagnosis, treatment and prognosis of tumors. With the deepening of research, genetically engineered antibodies will play a more important role. Now reviewed the latest progress in the use of genetically engineered antibodies in cancer.